Abnormal anterior cingulate N-acetylaspartate and executive functioning in treatment-resistant depression after rTMS therapy

International Journal of Neuropsychopharmacology

Volumn 18, Issue 11, 2015, Pages

  Zheng, Huirong ^a   Jia, Fujun ^a   Guo, Guangquan ^a   Quan, Dongming ^a   Li, Gang ^a   Wu, Huawang ^a,b   Zhang, Bin ^a   Fan, Changhe ^a   He, Xiajun ^a   Huang, Huiyan ^c  

^a GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

1H MRS; Anterior cingulate; Depression; Executive functioning; N acetylaspartate; rTMS

Indexed keywords

CHOLINE; ESCITALOPRAM; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; TASK PERFORMANCE; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; TREATMENT RESISTANT DEPRESSION; WISCONSIN CARD SORTING TEST; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CINGULATE GYRUS; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; ASPARTIC ACID; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; GYRUS CINGULI; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84984679358     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv059     Document Type: Article

References (63)

1. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P (2001) The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann NY Acad Sci 935:107-117.
2. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectros-copy study. Biol Psychiatry 47:305-313.
3. Baeken C, De Raedt R, Van Hove C, Clerinx P, De Mey J, Bossuyt A (2009) HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectr 14:439-448.
4. Beck AT, Beamesderfer A (1974) Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 7:151-169.
5. Benarroch EE (2008) N-Acetylaspartate and N-acetylaspartyl-glutamate neurobiology and clinical signifcance. Neurology 70:1353-1357.
6. Berlim MT, Turecki G (2007) Defnition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. CanJ Psychiatry 52:46-54.
7. Burghardt NS, Park EH, Hen R, Fenton AA (2012) Adult-born hip-pocampal neurons promote cognitive fexibility in mice. Hippocampus 22:1795-1808.
8. Burtscher IM, Holtas S (2001) Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 13:560-567.
9. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213.
10. Castrén E (2004) Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol Neurobiol 29:289-301.
11. Chen C-S, Chiang I, Li C-W, Lin W-C, Lu C-Y, Hsieh T-J, Liu G-C, Lin H-F, Kuo Y-T (2009) Proton magnetic resonance spectroscopy of late-life major depressive disorder. Psychiatry Res Neuro-imaging 172:210-214.
12. Cotter DR, Pariante CM, Everall IP (2001) Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 55:585-595.
13. Cousins DA, Grunze H (2012) Interpreting magnetic resonance imaging fndings in bipolar disorder. CNS Neurosci Ther 18:201-207.
14. Das P, Tanious M, Fritz K, Dodd S, Dean OM, Berk M, Malhi GS (2013) Metabolite profles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo. Aus New Zeal J Psychiatry 47:347-354.
15. Davidson RJ, Irwin W, Anderle MJ, Kalin NH (2003) The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psych 160:64-75.
16. Drevets WC, Savitz J, Trimble M (2008) The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 13:663.
17. Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S (2000) Executive dysfunction predicts nonresponse to fuoxetine in major depression. J Affect Disord 60:13-23.
18. Fitzgerald P (2003) Is it time to introduce repetitive transcranial magnetic stimulation into standard clinical practice for the treatment of depressive disorders? Aus New Zeal J Psychiatry 37:5-11; discussion 12-14.
19. Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, Jonas DE, Swinson Evans T, Viswanathan M, Lohr KN (2014) Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry 75:477-489.
20. George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li X-B, Arana GW, Risch SC, Ballenger JC (2000) A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 48:962-970.
21. Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S (2006) The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 30:120-125.
22. Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coeffcient and quantitative histopathology in human glioma. J Neurooncol 50:215-226.
23. Gutierrez R, McKercher R, Galea J, Jamison K (2005) Lamotrigine augmentation strategy for patients with treatment-resistant depression. CNS Spect 10:800-805.
24. Hamilton M (1960) A rating scale for depression. J Neurol Neuro-surg Psychiatry 23:56-62.
25. Heaton RK, Chelune G, Talley JL, Kay G, Curtiss G (1993) Wisconsin card sorting test manual. Odessa, FL: Psychological Assessment Resources.
26. Hisaoka K, Nishida A, Koda T, Miyata M, Zensho H, Morinobu S, Ohta M, Yamawaki S (2001) Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 79:25-34.
27. Kanner AM (2004) Structural MRI changes of the brain in depression. Clin EEG Neurosci 35:46-52.
28. Kennedy SH, Evans KR, Kruger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ (2001) Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psych 158:899-905.
29. Kusumakar V, MacMaster FP, Gates L, Sparkes SJ, Khan SC (2001) Left medial temporal cytosolic choline in early onset depression. Canadian J Psychiatry 46:959-964.
30. Lisanby SH, Gutman D, Luber B, Schroeder C, Sackeim HA (2001) Sham TMS: intracerebral measurement of the induced electrical feld and the induction of motor-evoked potentials. Biol Psychiatry 49:460-463.
31. Little JT, Kimbrell TA, Wassermann EM, Grafman J, Figueras S, Dunn RT, Danielson A, Repella J, Huggins T, George MS (2000) Cognitive effects of 1-and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary report. Cogn Behav Neurol 13:119-124.
32. Lorenzetti V, Allen NB, Fornito A, Yücel M (2009) Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord 117:1-17.
33. Machado-Vieira R, Yuan P, Brutsche N, DiazGranados N, Lucken-baugh D, Manji HK, Zarate CA, Jr. (2009) Brain-derived neu-rotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist. J Clin Psychiatry 70:1662-1666.
34. Martis B, Alam D, Dowd SM, Hill SK, Sharma RP, Rosen C, Pliskin N, Martin E, Carson V, Janicak PG (2003) Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol 114:1125-1132.
35. Mayberg HS (2003) Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 13:805-815.
36. Merkl A, Schubert F, Quante A, Luborzewski A, Brakemeier E-L, Grimm S, Heuser I, Bajbouj M (2011) Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biol Psychiatry 69:772-779.
37. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA (1999) Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psych 156:780-782.
38. Michael N, Gösling M, Reutemann M, Kersting A, Heindel W, Arolt V, Pfeiderer B (2003) Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefron-tal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci 17:2462-2468.
39. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89-131.
40. Padberg F, Zwanzger P, Keck ME, Kathmann N, Mikhaiel P, Ella R, Rupprecht P, Thoma H, Hampel H, Toschi N, Moller HJ (2002) Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between effcacy and stimulation intensity. Neuropsychopharmacology 27:638-645.
41. Paillere Martinot ML, Galinowski A, Ringuenet D, Gallarda T, Lefaucheur JP, Bellivier F, Picq C, Bruguiere P, Mangin JF, Riviere D, Willer JC, Falissard B, Leboyer M, Olie JP, Artiges E, Martinot JL (2010) Infuence of prefrontal target region on the effcacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fuorodeoxy-glucose PET and MRI study. Int J Neuropsychop 13:45-59.
42. Pascual-Leone A, Rubio B, Pallardo F, Catala MD (1996) Rapid-rate transcranial magnetic stimulation of left dorsolateral pre-frontal cortex in drug-resistant depression. Lancet 348:233-237.
43. Paus T, Castro-Alamancos MA, Petrides M (2001) Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci 14:1405-1411.
44. Pfeiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, Fiebich M, Arolt V, Heindel W (2003) Effective elec-troconvulsive therapy reverses glutamate/glutamine defcit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 122:185-192.
45. Rajkowska G (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766-777.
46. Richard-Devantoy S, Gorwood P, Annweiler C, Olie J-P, Le Gall D, Beauchet O (2012) Suicidal behaviours in affective disorders: a defcit of cognitive inhibition? Can J Psychiatry 57:254-262.
47. Richieri R, Boyer L, Farisse J, Colavolpe C, Mundler O, Lancon C, Guedj E (2011) Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. Eur J Nucl Med Mol Imaging 38:1715-1722.
48. Rogers MA, Kasai K, Koji M, Fukuda R, Iwanami A, Nakagome K, Fukuda M, Kato N (2004) Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res 50:1-11.
49. Sackeim HA (2001) The defnition and meaning of treatment-resistant depression. J Clin Psychiatry 62(Supp 16):10-17.
50. Schaller G, Sperling W, Richter-Schmidinger T, Muhle C, Heber-lein A, Maihofner C, Kornhuber J, Lenz B (2014) Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers. J Neural Transm 121:307-313.
51. Schulze-Rauschenbach SC, Harms U, Schlaepfer TE, Maier W, Falkai P, Wagner M (2005) Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and elec-troconvulsive therapy in major depression. Br J Psychiatry 186:410-416.
52. Schutter D (2009) Antidepressant effcacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 39:65.
53. Seminowicz D, Mayberg H, McIntosh A, Goldapple K, Kennedy S, Segal Z, Raf-Tari S (2004) Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 22:409-418.
54. Silvanto J, Pascual-Leone A (2008) State-dependency of transcra-nial magnetic stimulation. Brain Topogr 21:1-10.
55. Trivedi MH, Greer TL (2014) Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord 152-154:19-27.
56. Van der Hart M, Czeh B, De Biurrun G, Michaelis T, Watanabe T, Natt O, Frahm J, Fuchs E (2001) Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry 7:933-941.
57. Murrough JW, Iacoviello B, Neumeister A, Charney DS, Iosifescu DV (2011) Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem 96:553-563.
58. Vasic N, Walter H, Hose A, Wolf RC (2008) Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: a voxel-based morphometry study. J Affect Disord 109:107-116.
59. Vythilingam M, Charles HC, Tupler LA, Blitchington T, Kelly L, Krishnan K (2003) Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry 54:744-750.
60. Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, Sch-nepf B, Boeker H, Boesiger P, Northoff G (2009) The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry 66:478-486.
61. Wang L, LaBar KS, Smoski M, Rosenthal MZ, Dolcos F, Lynch TR, Krishnan RR, McCarthy G (2008) Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. Psychiatry Res 163:143-155.
62. Yildiz-Yesiloglu A, Ankerst DP (2006) Review of 1H magnetic resonance spectroscopy fndings in major depressive disorder: a meta-analysis. Psychiatry Res Neuroimaging 147:1-25.
63. Zheng H, Zhang L, Li L, Liu P, Gao J, Liu X, Zou J, Zhang Y, Liu J, Zhang Z, Li Z, Men W (2010) High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression. Prog Neuropsychopharma-col Biol Psychiatry 34:1189-1195.